This recall involves bottles of the prescription drug Evrysdi, a prescription medicine used to treat spinal muscular atrophy (SMA) in adults and children 2 months of age and older. The recalled 100 mL amber bottles have “Evrysdi (risdiplam) for oral solution,” the dosage and “NDC 20242-175-07” on the front of the bottle labels.
Name of product:
Evrysdi™ (risdiplam)
Hazard:
The bottles containing the prescription drug can leak due to a fit issue between the press-in bottle adapter and bottleneck. If the bottle is leaking, there is a risk of drug exposure by contact with skin or eyes. Prescription drugs must be in child resistant packaging that prevents children from gaining access to the contents as required by the Poison Prevention Packaging Act (PPPA).
Recall date:
March 18, 2021
Units:
About 14,000
Remedy:
Replace
Incidents/Injuries:
Genentech has received 26 reports of leaking bottles. No injuries have been reported.
Sold at:
Select specialty pharmacies nationwide as a prescribed medicine from August 2020 through the present. The price of the medication varies based on health insurance terms and other factors.
Manufactured In:
Switzerland
Recall number:
21-792
Source: CPSC